It may be an oversimplification, but the two major

It may be an oversimplification, but the two major issues for Antigen Express were time and money. The previous epidemics were short-lived (thank God) and there wasn't adequate time to develop the specific platforms necessary for creating a vaccine. Until recently Generex has never had adequate funding. Now we are told the "check (maybe multiple checks) is in the mail". Most of us believe that to be true, so NGIO should have funding to completer their trials.

COVID will not go away on its own. Perhaps NGIO can help it to go underground and bury it.